By Noel Saraf Poddar
India’s deep-tech story is entering a more consequential phase. The question is no longer whether the country can produce breakthrough technologies, but whether it can build the capital architecture needed to turn those breakthroughs into enduring global businesses.
The successful orbital launch of Skyroot Aerospace’s Vikram-I was a marker of how far India’s private deep-tech ecosystem has come. The ecosystem is expanding rapidly, with India now home to more than 4,200 deep-tech startups and deep-tech companies raising $2.3 billion in 2025, up 37% year-on-year. But the funding momentum has not been linear, with capital flows moderating even as investor interest and deal activity remain firm.
That divergence matters. India does not lack ideas or early investor interest. The harder question is what happens after early validation, when companies must move from proof-of-concept to commercialisation, and from there to industrial scale. Patient capital is necessary, but it is no longer enough.
Deep tech has always required patience; these businesses cannot be built on software-style timelines. But patience describes duration, not behaviour.
What deep-tech companies increasingly need is continuity capital, capable of staying invested as the nature of risk changes. Risk does not disappear, it transforms: scientific risk becomes engineering risk, then manufacturing risk, and eventually commercial risk. Capital must evolve with each of these transitions rather than being organised solely around funding stages.
Family offices can play a distinctive role here. Their advantage is often described as long-term thinking, but the more important one may be flexibility. Unlike institutional funds constrained by fixed cycles, family offices can follow a company across its lifecycle, deepening exposure as risk reduces and treating it not as a sequence of funding rounds but as a single, evolving thesis.
Many Indian family offices also bring operating experience from manufacturing, chemicals, automotive, pharmaceuticals or logistics. That can provide access to suppliers, customers and industry networks that may be as valuable as the funding itself.
This is not about replacing venture capital. Specialist VCs remain critical partners; family offices can complement them by providing continuity as capital needs increase and execution risk changes.
The real gap is between invention and industry. The hardest distance is often not between zero and one, but between one and a hundred, between a working prototype and a scalable industrial business. That journey can involve regulatory approvals, long procurement cycles and new manufacturing infrastructure before meaningful revenue emerges.
Traditional financial metrics struggle to capture this journey. Deep-tech value compounds through intellectual property, engineering depth and manufacturing capability, assets whose value may only become visible over time. Investors need to ask not simply whether the technology works, but what needs to be true to reach the next inflection point, how much capital that takes, and whether conviction increases as each risk is removed.
Commercialisation in deep tech is not a single event. It is a sequence of de-risking milestones, and family offices have a role beyond capital allocation: connecting founders with industry, opening customer channels and bringing strategic perspective as companies move from lab to market.
Value creation in deep tech can be back-ended, with early capital flowing into research, engineering, talent and infrastructure rather than immediate revenue. The distinction is between capital being consumed and capability being compounded. A company reinvesting in engineering or manufacturing may look less efficient through a short-term lens while strengthening the moat that determines its long-term value.
India has demonstrated that it can produce world-class technical talent and ambitious deep-tech founders. The next challenge is ensuring its capital structures evolve alongside that ambition. Deep tech is not conventional venture investing with a longer holding period. It is a compounding process spanning science, engineering, manufacturing and markets, with each stage building the foundation for the next.
The investors best suited to that journey will not necessarily be those who enter earliest or exit fastest, but those who maintain conviction as the risk evolves, staying present through the entire arc, from scientific discovery to commercial product to industry.
India does not just need more patient capital for deep tech. It needs capital capable of staying the course from innovation to industry.
The author is Vice President, Treasury, UAL Industries Limited.
Disclaimer: The views expressed are the author’s own and do not reflect the official policy or position of Financial Express.